An Immuno-Therapy Study of Experimental Medication BMS-986205 Given With Nivolumab With or Without Chemotherapy Compared to Chemotherapy in Participants With Previously Untreated Stage IV or Recurrent Non-Small Cell Lung Cancer
Public ClinicalTrials.gov record NCT03417037. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3 Open Label, Randomized Study of BMS-986205 Combined With Nivolumab With or Without Chemotherapy Versus Chemotherapy in Participants With Previously Untreated Stage IV or Recurrent Non-Small Cell Lung Cancer
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a study of experimental medication BMS-986205 given with Nivolumab with or without chemotherapy compared to chemotherapy in participants with previously untreated stage IV or recurrent non-small cell lung cancer.
Study identification
- NCT ID
- NCT03417037
- Recruitment status
- Withdrawn
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- Not listed
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 24, 2018 (Estimated)
- Primary completion
- Apr 25, 2021 (Estimated)
- Completion
- Aug 20, 2025 (Estimated)
- Last update posted
- Apr 30, 2018
2018 – 2025
United States locations
- U.S. sites
- 19
- U.S. states
- 13
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Local Institution | San Diego | California | 92123 | — |
| Local Institution | Fort Myers | Florida | 33916 | — |
| Local Institution | Jacksonville | Florida | 32256 | — |
| Local Institution | St. Petersburg | Florida | 33705 | — |
| Local Institution | Tallahassee | Florida | 32308 | — |
| Local Institution | West Palm Beach | Florida | 33401 | — |
| Local Institution | Decatur | Georgia | 30033 | — |
| Local Institution | Marietta | Georgia | 30060 | — |
| Local Institution | Wichita | Kansas | 67214 | — |
| Local Institution | Louisville | Kentucky | 40202 | — |
| Local Institution | Boston | Massachusetts | 02114 | — |
| Local Institution | Bridgeton | Missouri | 63044 | — |
| Local Institution | Lincoln | Nebraska | 68510 | — |
| Local Institution | Cleveland | Ohio | 44106 | — |
| Local Institution | Gettysburg | Pennsylvania | 17325 | — |
| Local Institution | Greenville | South Carolina | 29607 | — |
| Local Institution | Lebanon | Tennessee | 37087 | — |
| Local Institution | Fort Worth | Texas | 76104 | — |
| Local Institution | Lubbock | Texas | 79430-0002 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 64 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03417037, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 30, 2018 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03417037 live on ClinicalTrials.gov.